Page
%P
-
Article
Open AccessThree doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant
We report the levels of neutralising antibodies against Wuhan, Delta and Omicron variants in unimmunized infected (group 1), immunised and boosted (group 2) and infected immunised and boosted (group 3) adult i...
-
Article
Open AccessAntibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants
Differences in innate immune ‘imprinting’ between vaccine adjuvants may mediate dissimilar effects on the quantity/quality of persisting adaptive responses. We compared antibody avidity maturation, antibody/me...
-
Article
Open AccessCD4+ T lymphocyte response to primary CMV infection
-
Article
Open AccessMother and fetal immunity to cytomegalovirus